BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

ZymoGenetics, Inc. 

1201 Eastlake Avenue East

Seattle  Washington  98102  U.S.A.
Phone: 206-442-6600 Fax: 206-442-6608


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Blaze Bioscience Inc., Fred Hutchinson Cancer Research Center Spinoff with ZymoGenetics, Inc. (ZGEN) Vet at the Helm, Seeks to "Paint" Tumors 10/18/2011 8:12:47 AM
Bristol-Myers Squibb Company (BMY) to Keep a Seattle Presence; to Preserve About 275 ZymoGenetics, Inc. (ZGEN) Jobs 1/26/2011 6:48:15 AM
ZymoGenetics, Inc. (ZGEN) CEO Doug Williams Exits the Stage, Mulls Next Free Agent Move 11/8/2010 7:48:09 AM
Bristol-Myers Squibb Company (BMY) Third Quarter Featured Solid Operating Performance, Robust Clinical Data and the Strategic Acquisition of ZymoGenetics, Inc. (ZGEN) 10/26/2010 9:39:13 AM
Bristol-Myers Squibb Company (BMY) Completes Acquisition of ZymoGenetics, Inc. (ZGEN) 10/13/2010 10:07:42 AM
Bristol-Myers Squibb Company (BMY) Completes Tender Offer for ZymoGenetics, Inc. (ZGEN) with 94.9% of Shares Tendered 10/8/2010 9:49:27 AM
Novo Nordisk A/S (NVO) Completes Divestment of ZymoGenetics, Inc. (ZGEN) 10/8/2010 9:16:05 AM
ZymoGenetics, Inc. (ZGEN) and Bristol-Myers Squibb Company (BMY) to Present PEG-Interferon Lambda Phase 2a Interim Clinical Trial Results at AASLD 2010 10/4/2010 10:40:57 AM
ZymoGenetics, Inc. (ZGEN) Reports Favorable Survival Data from IL-21 Phase 2a Clinical Trial in Melanoma 9/29/2010 9:55:42 AM
ZymoGenetics, Inc. (ZGEN)'s Skin Cancer Drug Shows Promise in Study 9/29/2010 6:37:13 AM
12345678910...